Home
Glaxosmithkline Pharmaceuticals Ltd Quarterly Result

Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
Net Profit - Last Quarter
Glaxosmithkline Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Glaxosmithkline Pharmaceuticals Ltd for the Mar '25 is ₹ 1015 crore as compare to the Dec '24 revenue of ₹ 984.49 crore.
- This represent the growth of 3.1%a1# The ebitda of Glaxosmithkline Pharmaceuticals Ltd for the Mar '25 is ₹ 373.87 crore as compare to the Dec '24 ebitda of ₹ 326.99 crore.
- This represent the growth of 14.34%a1# The net profit of Glaxosmithkline Pharmaceuticals Ltd for the Mar '25 is ₹ 262.87 crore as compare to the Dec '24 net profit of ₹ 229.88 crore.
- This represent the growth of 14.35%a1#.
Glaxosmithkline Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Glaxosmithkline Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
20 May 2025 | 2787.3 |
19 May 2025 | 2820.15 |
16 May 2025 | 2827.6 |
15 May 2025 | 2878.7 |
14 May 2025 | 2877.1 |
13 May 2025 | 2790.15 |
12 May 2025 | 2721.25 |
09 May 2025 | 2758.3 |
08 May 2025 | 2740.95 |
07 May 2025 | 2847.6 |
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd News Hub
Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter
Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju
Read more
05 Aug 24
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju
Read more
03 Aug 24
GlaxoSmithKline Pharmaceuticals to conduct board meeting
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 M
Read more
19 Apr 25
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O
Read more
25 Oct 24
Document
Concalls